fibrinogen has been researched along with Breast Neoplasms in 110 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 30 (27.27) | 18.7374 |
| 1990's | 10 (9.09) | 18.2507 |
| 2000's | 23 (20.91) | 29.6817 |
| 2010's | 35 (31.82) | 24.3611 |
| 2020's | 12 (10.91) | 2.80 |
| Authors | Studies |
|---|---|
| Lipke, EA; Minond, D; Pradhan, S; Seeto, WJ; Tian, Y | 1 |
| Liu, H; Mei, Y; Xiang, L | 1 |
| Castle, J; Descamps, T; Kirwan, CC | 1 |
| Chen, S; Wu, C; Yan, H; Zheng, Y | 1 |
| Li, W; Liu, F; Liu, P; Liu, Y; Yang, Y; Zhang, H; Zhao, Y; Zheng, L | 1 |
| Feng, Y; Guo, C; Huang, G; Wang, H; Wang, T; Wang, W; Yuan, K; Zhao, L | 1 |
| Wang, Y; Xu, W | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Bester, J; de Waal, GM; Goncalves, JPN; Holst, F; Page, MJ; Pretorius, E; Roberts, T; Venter, C | 1 |
| Agodirin, OS; Izuegbuna, OO; Olatoke, SA; Olawumi, HO | 1 |
| Bi, Z; Chen, P; Liu, YB; Song, XG; Song, XR; Wang, CJ; Wang, YS; Xie, L; Zhang, ZP; Zhao, T | 1 |
| Chen, R; Dai, Y; Ding, N; Jiang, L; Jin, Y; Lan, A; Liu, S; Peng, Y; Tang, Z; Wang, Y | 1 |
| Feng, L; Han, R; Huang, S; Meng, M; Ren, J; Wang, G; Yuan, N; Zhang, Y; Zhao, X | 1 |
| Li, X; Liu, H; Ma, R; Mei, Y; Sun, X; Zhao, S | 1 |
| Akinkuolie, AO; Buring, JE; Chandler, PD; Lawler, PR; Lee, IM; Manson, JE; Mora, S; Ridker, PM; Tobias, DK; Wang, L | 1 |
| Canino, J; Canobbio, I; Guidetti, GF; Torti, M; Visconte, C; Zarà, M | 1 |
| Bugert, P; Graf, ME; Hoffmeister, M; Johnson, T; Kaaks, R; Katzke, V; Kühn, T; Maldonado, SG; Pletsch-Borba, L; Schübel, R; Sookthai, D | 1 |
| Andrieu, C; Berclaz, G; Canonica, C; Cassoly, E; Chiesa, F; Dedes, KJ; Fehr, MK; Fehr, PM; Gabriel, N; Güth, U; Hawle, H; Hayoz, S; Hess, T; Knauer, M; Lelièvre, L; Leo, C; Lupatsch, JE; Matter-Walstra, K; Pioch, V; Ribi, K; Ruhstaller, T; Sarlos, D; Soysal, SD; Tausch, C; Weber, WP; Zeindler, J | 1 |
| Hu, YB; Luo, BP; Luo, J; Wu, FH; Yao, XW | 1 |
| Baby, T; Jayakumar, R; Nair, SV; Rejinold, NS | 1 |
| Akerman, G; Barranger, E; Bonneau, C; Bricou, A; Lesavre, M; Raiffort, C; Vinchant, M | 1 |
| Cash, JG; Dentler, MD; Retzinger, AC; Retzinger, GS; Thacker, RI | 1 |
| Alger, PW; Ley, ML; Matika, RW; Nielsen, VG; Steinbrenner, EB; Waer, AL | 1 |
| Baby, T; Chennazhi, KP; Jayakumar, R; Rejinold, NS | 2 |
| Álvarez-Benito, M; Bascuñana-Estudillo, G; Briceño-Delgado, J; Ciria-Bru, R; Díaz-Jiménez, N; Gómez-Luque, I; Navarro-Rodríguez, E; Rioja-Torres, P; Rufián-Peña, S; Ruiz-Rabelo, JF | 1 |
| Barranger, E; Bricou, A | 1 |
| Mony, U; Rangasamy, J; Sreerenganathan, M | 1 |
| Hu, BQ; Ji, YR; Liang, B; Liang, JW; Liu, YL; Lu, Q; Shang, FF; Wang, J; Wang, Q; Xia, Y; Zhang, W | 1 |
| Kabat, GC; Lane, DS; Rohan, TE; Salazar, CR; Zaslavsky, O | 1 |
| Gerger, A; Kapp, KS; Krenn-Pilko, S; Langsenlehner, T; Langsenlehner, U; Pichler, M; Stojakovic, T | 1 |
| Acosta, D; Caldés, T; de la Hoya, M; de Las Heras, N; Díaz-Millán, I; Díaz-Rubio, E; Lahera, V; López Farré, A; Melander, O; Modrego, J; Perez-Segura, P; Rico Zalba, LA; Santos-Sancho, JM; Zamorano-León, JJ | 1 |
| Huang, X; Li, S; Wang, Q; Wen, J; Xie, X; Yang, Y; Ye, F | 1 |
| Chen, L; Chen, W; Huang, C; Huang, S; Li, M; Li, Y; Liu, Y; Lu, Y; Qian, W; Tao, L; Wang, A; Wang, Y; Yue, Z; Zhang, F; Zhang, L | 1 |
| Li, X; Liu, H; Lu, X; Ma, R; Mei, Y; Zhao, S | 1 |
| Hassani, I; Lipke, EA; Pradhan, S; Seeto, WJ | 1 |
| Clark, AM; Griffith, L; Lauffenburger, D; Shepard Neiman, J; Stockdale, L; Stolz, DB; Venkataramanan, R; Wells, A; Wheeler, SE; Young, CL; Zhao, W | 1 |
| Cakar, B; Erdem, D; Gönüllü, G; Turgut, M; Yigit, E; Yücel, I | 1 |
| Arévalo, MT; Sahni, A; Sahni, SK; Simpson-Haidaris, PJ | 1 |
| Hyspler, R; Kalábová, H; Krcmová, L; Melichar, B; Melicharová, K; Pecka, M; Solichová, D; Urbánek, L; Zadák, Z | 1 |
| Beijnen, JH; Schellens, JH; Sparidans, RW; van den Broek, I | 1 |
| Beijnen, JH; Cats, A; Depla, AC; Engwegen, JY; Gast, MC; Peeters, PH; Schellens, JH; Sparidans, RW; van den Broek, I; van Dulken, EJ; van Gils, CH; van Winden, AW | 1 |
| Aigbe, A; Egwakhide, E; Elusoji, C; Elusoji, SO; Famodu, AA; Iribhogbe, PE; Oludiran, O; Oluedo, A; Osime, C | 1 |
| Koolwijk, P; van Hinsbergh, VW; van Nieuw Amerongen, GP; Weijers, EM | 1 |
| Kaftan, O; Kasapoglu, B; Koroglu, M; Kosar, A; Yalcin, SK | 1 |
| Chennazhi, KP; Jayakumar, R; Muthunarayanan, M; Nair, SV; Rejinold, NS | 1 |
| Alekberov, DG; Potanin, VP | 1 |
| Betti, M; Buda, A; Fruscio, R; Milani, R; Pirovano, C; Signorelli, M | 1 |
| Hyšpler, R; Kalábová, H; Kašparová, M; Krčmová, L; Melichar, B; Pecen, L; Pecka, M; Procházková-Študentová, H; Solichová, D; Šrámek, V; Svobodník, A; Ungermann, L | 1 |
| Frolova, VIu; Gantsev, ShKh; Ishmuratova, RSh; Sultanbaev, AV | 1 |
| Body, G; Lacoste, C; Marret, H; Ouldamer, L | 1 |
| Bayer, E; Gelbmann, D; Gerner, C; Peter, B; Posovszky, C; Schulte-Hermann, R; Vejda, S; Zelzer, S | 1 |
| Ebano, V; Fruscella, M; Imperato, F; Marziani, R; Mossa, B; Perniola, G | 1 |
| Fábregas, P; Félez, J; Hawley, S; Jardí, M; Longstaff, C; López-Alemany, R; Merton, E; Miles, LA; Mirshahi, M | 1 |
| Felding-Habermann, B; Fransvea, E; Pilch, J; Rolli, M; Saven, A | 1 |
| Genç, S; Gürdöl, F; Lama, A; Tanrikulu-Kiliç, F; Uler, P; Unlüçerçi, Y; Unur, N | 1 |
| Blann, AD; Caine, GJ; Lip, GY; Nadar, SK; Stonelake, PS | 1 |
| Caputo, E; Guardiola, J; Lombardi, ML; Luongo, V; Martin, BM; Moharram, R; Pirozzi, G; Tornatore, P | 1 |
| Bradley, LM; Ding, Y; Fasco, MJ; Gierthy, JF; Pentecost, BT | 1 |
| Bauchspiess, R; do Carmo Araújo, M; Morsch, A; Morsch, VM; Rocha, JB; Schetinger, MR; Zanin, R | 1 |
| Chow, C; Danforth, D; Eng-Wong, J; Gantz, S; Liewehr, D; Liu, ET; Reynolds, JC; Venzon, D; Zujewski, J | 1 |
| Gentleman, R; Harris, LN; Hwang, J; Iglehart, JD; Li, X; Lu, X; Miron, A; Shi, Q | 1 |
| Barhua, TA; Egbagbe, EE; Egwaikhide, E; Fakoya, AA; Famodu, ES; Olu-Edo, AN; Osime, CO; Osime, EO | 1 |
| Bale, WF; Dewey, WC; Harper, PV; Marrack, D; McCardle, RJ; Spar, IL | 1 |
| Johansson, SA | 1 |
| Galloway, MJ; Mackie, MJ; McVerry, BA | 1 |
| Due, J; Osterud, B | 1 |
| Al-Mondhiry, H; Leitzel, K; McGarvey, V | 1 |
| Gallus, AS; McCulloch, PB; Pineo, GF; Williams, CK | 1 |
| Ashley, SE; Baum, M; Cosgrove, D; Jones, AL; Nash, AG; O'Brien, ME; Powles, TJ; Sacks, N; Tidy, VA; Treleavan, J | 1 |
| Ito, Y; Katsumoto, Y; Kobayashi, T; Monden, T; Mori, T; Shimano, T; Takeda, T; Tomita, N; Wakasugi, E; Wakasugi, T | 1 |
| Abe, O; Aoki, N; Asaishi, K; Enomoto, K; Izuo, M; Koyama, H; Nomura, Y; Ohshima, A; Tominaga, T; Tsukada, T | 1 |
| Dietrich, M; Heilmann, L; Hommel, G; von Tempelhoff, GF | 1 |
| Ashley, SE; Chang, J; Gregory, RK; Powles, TJ; Singh, R; Tidy, VA; Treleaven, JG | 1 |
| Chinchilli, VM; Costa, LA; Demers, LM; Harvey, HA; Kopreski, MS; Lipton, A; Santen, RJ | 1 |
| Rybarczyk, BJ; Simpson-Haidaris, PJ | 1 |
| Heilmann, L; Hommel, G; Nieman, F; von Tempelhoff, GF | 1 |
| Buckley, L; Costantino, JP; Cushman, M; Krag, DN; Roberts, JD; Song, K; Tracy, RP | 1 |
| Ruoslahti, E; Yi, M | 1 |
| Bareford, D; Blann, AD; Gurney, D; Lip, GY; Stonelake, P; Wadley, M | 1 |
| Heilmann, L; Hommel, G; von Tempelhoff, GF | 1 |
| Heilmann, L; Hommel, G; Pollow, K; Schönmann, N; von Tempelhoff, GF | 1 |
| Ambrosetti, A; Molino, AM; Pizzolo, G; Savarin, T; Todeschini, G; Vettore, L | 1 |
| Hofmann, V; Mombelli, G; Straub, PW | 1 |
| Armani, U; Longo, A; Mandorla, P; Piana, A; Ponte, M; Turco, S | 1 |
| Ashley, SE; Burman, JF; Chung, HI; Jones, AL; Nicolson, MC; Powles, TJ; Treleaven, JG | 1 |
| Love, RR; Surawicz, TS; Williams, EC | 1 |
| Ambartsumian, AM; Khachaturova, TS; Magakian, AG; Mkrtchian, LN; Sarkisian, OM; Shukurian, SG | 1 |
| Douglas, JT; George, WD; Lowe, GD; McCulloch, P; Murray, GD | 1 |
| Brass, B; Harsch, U; Heimpel, H; Kreuser, ED; Schreml, W; Seifried, E | 1 |
| Ashley, SE; Cosgrove, D; Davey, JB; Dowsett, M; Hardy, JR; McKinna, A; Nash, AG; Powles, TJ; Rundle, SK; Sinnett, HD | 1 |
| Douglas, J; George, WD; Lowe, GD; McCulloch, P; Murray, G | 1 |
| Bianchi Bonomi, A; Cugno, M; Mameli, G; Mannucci, PM; Marongiu, F | 1 |
| Heilmann, L; Miller, B | 1 |
| Auger, MJ; Galloway, MJ; Leinster, SJ; Mackie, MJ; McVerry, BA | 1 |
| Abecassis, J; Beretz, A; Cazenave, JP; Eber, M; Fricker, JP; Klein-Soyer, C; Millon-Collard, R; Muller, D; Nicora, F | 1 |
| Ardizzoni, A; Bruzzi, P; Canobbio, L; Di Giorgio, F; Fassio, T; Queirolo, MA; Rosso, R; Santi, L; Zarcone, D | 1 |
| Rieche, K | 2 |
| Bouwer, EL; Rosenstrauch, WJ; van Zyl, JA | 1 |
| Kjartansson, I; Korsan-Bengtsen, K; Peterson, HI; Rudenstam, CM; Zettergren, L | 1 |
| Carlsson, S | 1 |
| Korsan-Bengtsen, K; Peterson, HI; Petrusson, B | 1 |
| Bettigole, RE; Clifford, GO; Himelstein, ES; Oettgen, HF | 1 |
| Yamamoto, M | 1 |
| Fukunaga, K; Nagamatsu, S; Nagashima, A; Yamada, T; Yamamoto, M | 1 |
| Bernell, WR; MacGee, EE | 1 |
| Azzopardi, JG; Baker, LR; Brain, MC; Dacie, JV; Pineo, GF; Roberts, PD | 1 |
| Bergut, FA; Gorodilova, VV; Saraeva, ZM | 1 |
| Genton, E; Wolf, PS | 1 |
2 review(s) available for fibrinogen and Breast Neoplasms
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
[Cancer chemotherapy and blood coagulation-fibrinolysis system].
Topics: Adult; Antineoplastic Agents; Blood Coagulation; Blood Coagulation Factors; Breast Neoplasms; Dextrans; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Rectal Neoplasms; Sulfates | 1971 |
14 trial(s) available for fibrinogen and Breast Neoplasms
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Markers of Inflammation and Incident Breast Cancer Risk in the Women's Health Study.
Topics: Age Factors; Aged; Biomarkers; Body Mass Index; Breast Neoplasms; C-Reactive Protein; Chronic Disease; Female; Fibrinogen; Health Behavior; Humans; Inflammation; Inflammation Mediators; Intercellular Adhesion Molecule-1; Middle Aged; Neoplasm Invasiveness; Proportional Hazards Models; Risk Factors; Women's Health | 2018 |
Impact of a Surgical Sealing Patch on Lymphatic Drainage After Axillary Dissection for Breast Cancer: The SAKK 23/13 Multicenter Randomized Phase III Trial.
Topics: Aged; Axilla; Breast Neoplasms; Drainage; Drug Combinations; Female; Fibrinogen; Health Care Costs; Humans; Length of Stay; Lymph Node Excision; Mastectomy, Segmental; Middle Aged; Pain, Postoperative; Thrombin; Wound Closure Techniques | 2018 |
Effectiveness of an absorbable fibrin sealant patch to reduce lymphoceles formation after axillary lymphadenectomy for breast cancer: a matched-pair analysis.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Drug Combinations; Female; Fibrin Tissue Adhesive; Fibrinogen; Humans; Logistic Models; Lymph Node Excision; Lymphocele; Matched-Pair Analysis; Middle Aged; Multivariate Analysis; Postoperative Complications; Thrombin; Treatment Outcome | 2014 |
Longitudinal association of hemostatic factors with risk for cancers of the breast, colorectum, and lung among postmenopausal women.
Topics: Aged; Breast Neoplasms; Colorectal Neoplasms; Factor VII; Female; Fibrinogen; Hemostatics; Humans; Longitudinal Studies; Lung Neoplasms; Middle Aged; Postmenopause; Prognosis; Prospective Studies | 2016 |
Effect of raloxifene on bone mineral density in premenopausal women at increased risk of breast cancer.
Topics: Adult; Bone Density; Breast Neoplasms; Female; Fibrinogen; Humans; Lipids; Middle Aged; Premenopause; Quality of Life; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2006 |
The Royal Marsden Hospital pilot tamoxifen chemoprevention trial.
Topics: Adult; Age Factors; Aged; Anticarcinogenic Agents; Antithrombin III; Bone Density; Breast Neoplasms; Cholesterol; Estrogen Replacement Therapy; Female; Fibrinogen; Follow-Up Studies; Humans; Menopause; Menstrual Cycle; Middle Aged; Nuclear Family; Ovary; Patient Compliance; Pilot Projects; Placebos; Risk Factors; Tamoxifen; Treatment Refusal; Ultrasonography | 1994 |
The effect of local immunotherapy for breast cancer using a mixture of OK-432 and fibrinogen supplemented with activated macrophages.
Topics: Breast Neoplasms; Drug Therapy, Combination; Female; Fibrinogen; Humans; Immunohistochemistry; Immunotherapy, Adoptive; Macrophage Activation; Macrophages; Picibanil | 1993 |
Effects of medroxyprogesterone acetate therapy on advanced or recurrent breast cancer and its influences on blood coagulation and the fibrinolytic system.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Antithrombin III; Blood Coagulation; Breast Neoplasms; Chi-Square Distribution; Cyclophosphamide; Doxorubicin; Factor X; Female; Fibrinogen; Fibrinolysis; Fluorouracil; Humans; Japan; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Protein C; Remission Induction | 1995 |
The effect of tamoxifen and hormone replacement therapy on serum cholesterol, bone mineral density and coagulation factors in healthy postmenopausal women participating in a randomised, controlled tamoxifen prevention study.
Topics: Aged; Antineoplastic Agents, Hormonal; Antithrombin III; Bone Density; Breast Neoplasms; Cholesterol; Double-Blind Method; Drug Interactions; Estrogen Replacement Therapy; Female; Fibrinogen; Follow-Up Studies; Humans; Middle Aged; Postmenopause; Reference Values; Risk Assessment; Sampling Studies; Tamoxifen | 1996 |
Tamoxifen and cardiac risk factors in healthy women: Suggestion of an anti-inflammatory effect.
Topics: Administration, Oral; Anti-Inflammatory Agents; Antineoplastic Agents, Hormonal; Blood Coagulation; Breast Neoplasms; C-Reactive Protein; Cardiovascular Diseases; Cardiovascular System; Cholesterol; Double-Blind Method; Female; Fibrinogen; Humans; Placebos; Postmenopause; Risk Factors; Selective Estrogen Receptor Modulators; Tamoxifen | 2001 |
Haemostatic changes and thromboembolic risk during tamoxifen therapy in normal women.
Topics: Antithrombins; Breast Neoplasms; Double-Blind Method; Family; Female; Fibrinogen; Humans; Menopause; Protein C; Protein S; Tamoxifen | 1992 |
Antithrombin III level, fibrinogen level, and platelet count changes with adjuvant tamoxifen therapy.
Topics: Antithrombin III; Breast Neoplasms; Double-Blind Method; Female; Fibrinogen; Humans; Platelet Count; Tamoxifen; Thrombophlebitis | 1992 |
Chemoprevention of breast cancer.
Topics: Adult; Aged; Antithrombin III; Bone Density; Breast Neoplasms; Cholesterol; Double-Blind Method; Estradiol; Feasibility Studies; Female; Fibrinogen; Humans; Middle Aged; Monitoring, Physiologic; Patient Compliance; Randomized Controlled Trials as Topic; Tamoxifen | 1989 |
95 other study(ies) available for fibrinogen and Breast Neoplasms
| Article | Year |
|---|---|
Droplet Microfluidics-Based Fabrication of Monodisperse Poly(ethylene glycol)-Fibrinogen Breast Cancer Microspheres for Automated Drug Screening Applications.
Topics: Breast Neoplasms; Drug Evaluation, Preclinical; Early Detection of Cancer; Female; Fibrinogen; Humans; Hydrogels; Microfluidics; Microspheres; Polyethylene Glycols; Tumor Microenvironment | 2022 |
miR-877-5p Inhibits Epithelial Mesenchymal Transformation of Breast Cancer Cells by Targeting FGB.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Female; Fibrinogen; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Neoplasm Invasiveness | 2022 |
Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antithrombin III; Biomarkers, Tumor; Breast Neoplasms; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Middle Aged; Neoplasm Metastasis; Neoplastic Cells, Circulating; Peptide Hydrolases; Prognosis; Survival Rate; Thrombophilia | 2020 |
Prognostic value of combined preoperative fibrinogen-albumin ratio and platelet-lymphocyte ratio score in patients with breast cancer: A prognostic nomogram study.
Topics: Adult; Breast Neoplasms; Cohort Studies; Female; Fibrinogen; Humans; Lymphocyte Count; Male; Middle Aged; Platelet Count; Regression Analysis; Serum Albumin | 2020 |
Prognostic significance of preoperative albumin to fibrinogen ratio associated nomograms in patients with breast invasive ductal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Disease-Free Survival; Female; Fibrinogen; Humans; Middle Aged; Nomograms; Preoperative Period; Prognosis; Retrospective Studies; Serum Albumin | 2020 |
Fibrinogen-Like Protein 2 (FGL2) is a Novel Biomarker for Clinical Prediction of Human Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Databases, Genetic; Female; Fibrinogen; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Protein Interaction Maps | 2020 |
Prognostic role of preoperative fibrinogen to albumin ratio in breast cancer.
Topics: Albumins; Biomarkers, Tumor; Breast Neoplasms; Female; Fibrinogen; Humans; Prognosis; Retrospective Studies | 2020 |
The Value of Detecting Pathological Changes During Clot Formation in Early Disease Treatment-Naïve Breast Cancer Patients.
Topics: Blood Coagulation; Blood Coagulation Tests; Breast Neoplasms; Female; Fibrinogen; Humans; Thrombosis | 2021 |
Plasma D-Dimer and Fibrinogen Levels Correlates with Tumor Size and Disease Progression in Nigerian Breast Cancer Patients.
Topics: Adult; Aged; Breast Neoplasms; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Middle Aged; Nigeria; Prognosis | 2021 |
Laboratory indicators predict axillary nodal pathologic complete response after neoadjuvant therapy in breast cancer.
Topics: Adult; Aged; Axilla; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fibrinogen; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Nomograms; Retrospective Studies; ROC Curve; Treatment Outcome | 2021 |
Plasma fibrinogen acts as a predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer: a retrospective study of 1004 Chinese breast cancer patients.
Topics: Adult; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fibrinogen; Humans; Logistic Models; Middle Aged; Neoadjuvant Therapy; Proportional Hazards Models; Retrospective Studies | 2021 |
The CNGRCLLII(KLAKLAK)2 peptide shows cytotoxicity against HUVECs by inducing apoptosis: An in vitro and in vivo study.
Topics: Adipose Tissue; Animals; Apoptosis; Breast Neoplasms; CD13 Antigens; Cell Line, Tumor; Female; Fibrinogen; Genetic Therapy; Human Umbilical Vein Endothelial Cells; Humans; Mice; Oligopeptides; Peptides; Stem Cells; Transfection; Xenograft Model Antitumor Assays | 2017 |
Plasma fibrinogen level may be a possible marker for the clinical response and prognosis of patients with breast cancer receiving neoadjuvant chemotherapy.
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Disease-Free Survival; Female; Fibrinogen; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Prognosis | 2017 |
Molecular mechanisms of platelet activation and aggregation induced by breast cancer cells.
Topics: Amino Acid Chloromethyl Ketones; Aspirin; Blood Platelets; Breast Neoplasms; Caco-2 Cells; Calcium Chloride; Colorectal Neoplasms; Female; Fibrin; Fibrinogen; Humans; Integrin alpha2; MCF-7 Cells; Platelet Activation; Platelet Aggregation; Thromboxane A2; Type C Phospholipases | 2018 |
Pre-diagnostic plasma concentrations of Fibrinogen, sGPIIb/IIIa, sP-selectin, sThrombomodulin, Thrombopoietin in relation to cancer risk: Findings from a large prospective study.
Topics: Adult; Autoantigens; Biomarkers, Tumor; Breast Neoplasms; CD36 Antigens; Colorectal Neoplasms; Female; Fibrinogen; Humans; Iodide Peroxidase; Iron-Binding Proteins; Male; Middle Aged; P-Selectin; Prospective Studies; Prostatic Neoplasms; Risk Factors; Thrombomodulin | 2018 |
Cyclin D1b Splice Variant Promotes αvβ3-mediated EMT Induced by LPS in Breast Cancer Cells.
Topics: Alternative Splicing; Breast Neoplasms; Cell Adhesion; Cell Movement; Cyclin D1; Epithelial-Mesenchymal Transition; Female; Fibrinogen; Homeodomain Proteins; Humans; Integrin alphaVbeta3; Lipopolysaccharides; MCF-7 Cells; Neoplasm Invasiveness; Neoplasm Metastasis; Transcription Factors; Transfection; Up-Regulation | 2018 |
Paclitaxel loaded fibrinogen coated CdTe/ZnTe core shell nanoparticles for targeted imaging and drug delivery to breast cancer cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cadmium Compounds; Cell Line, Tumor; Diffusion; Female; Fibrinogen; Humans; Mice; Nanocapsules; Paclitaxel; Tellurium; Zinc | 2013 |
[Interest of a thrombin and fibrinogen combipatch in preventing breast cancer seroma after lymph node dissection].
Topics: Administration, Cutaneous; Adult; Aged; Axilla; Breast Neoplasms; Case-Control Studies; Drug Combinations; Female; Fibrinogen; Humans; Lymph Node Excision; Middle Aged; Retrospective Studies; Seroma; Surgical Sponges; Thrombin | 2013 |
Extracellular transport of cell-size particles and tumor cells by dendritic cells in culture.
Topics: Biological Transport; Breast Neoplasms; CD18 Antigens; Cell Movement; Cell Size; Cells, Cultured; Coated Materials, Biocompatible; Dendritic Cells; Extracellular Space; Female; Fibrinogen; Humans; Monocytes | 2013 |
Plasmatic hypercoagulation in patients with breast cancer: role of heme oxygenase-1.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Blood Coagulation Tests; Breast Neoplasms; Carbon Monoxide; Carboxyhemoglobin; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fibrinogen; Heme Oxygenase-1; Humans; Mastectomy, Radical; Mastectomy, Segmental; Middle Aged; Up-Regulation | 2013 |
Dual drug encapsulated thermo-sensitive fibrinogen-graft-poly (N-isopropyl acrylamide) nanogels for breast cancer therapy.
Topics: Acrylic Resins; Animals; Apoptosis; Breast Neoplasms; Cattle; Drug Delivery Systems; Female; Fibrinogen; Flow Cytometry; Fluorouracil; Hemolysis; Humans; Indoles; Macrophages; MCF-7 Cells; Mice; Nanogels; Particle Size; Polyethylene Glycols; Polyethyleneimine; Solutions; Spectroscopy, Fourier Transform Infrared; Surface Properties; Temperature | 2014 |
Response to the article by Rodríguez et al: "effectiveness of an absorbable fibrin sealant patch to reduce lymphoceles formation after axillary lymphadenectomy for breast cancer: a matched-pair analysis." Am J Surg 2014.
Topics: Adenocarcinoma; Breast Neoplasms; Female; Fibrin Tissue Adhesive; Fibrinogen; Humans; Lymph Node Excision; Lymphocele; Postoperative Complications; Thrombin | 2015 |
Thermo-responsive fibrinogen nanogels: a viable thermo-responsive drug delivery agent for breast cancer therapy?
Topics: Antineoplastic Agents; Breast Neoplasms; Delayed-Action Preparations; Drug Delivery Systems; Female; Fibrinogen; Gels; Humans; Nanoparticles; Temperature | 2014 |
High plasma fibrinogen is correlated with poor response to trastuzumab treatment in HER2 positive breast cancer.
Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Breast Neoplasms; Disease-Free Survival; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Kaplan-Meier Estimate; Middle Aged; Partial Thromboplastin Time; Prognosis; Prothrombin Time; Receptor, ErbB-2; Retrospective Studies; Trastuzumab | 2015 |
Multi Drug Loaded Thermo-Responsive Fibrinogen-graft-Poly(N-vinyl Caprolactam) Nanogels for Breast Cancer Drug Delivery.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Caprolactam; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Diffusion; Fibrinogen; Fluorouracil; Humans; Hydrogels; Megestrol Acetate; Nanocapsules; Particle Size; Polymers; Receptors, Vitronectin; Temperature | 2015 |
An elevated preoperative plasma fibrinogen level is associated with poor disease-specific and overall survival in breast cancer patients.
Topics: Aged; Biomarkers, Tumor; Breast Neoplasms; Female; Fibrinogen; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Middle Aged; Predictive Value of Tests; Preoperative Period; Prognosis; Proportional Hazards Models; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Survival Rate | 2015 |
BRCA2 gene mutations and coagulation-associated biomarkers.
Topics: Adult; alpha 1-Antitrypsin; Binding Sites; Biomarkers; Blood Coagulation; BRCA2 Protein; Breast Neoplasms; Case-Control Studies; DNA Mutational Analysis; Female; Fibrinogen; Genetic Predisposition to Disease; Haptoglobins; Heterozygote; Humans; Middle Aged; Mutation; P-Selectin; Platelet Factor 4; Rad51 Recombinase; Transferrin | 2016 |
The preoperative plasma fibrinogen level is an independent prognostic factor for overall survival of breast cancer patients who underwent surgical treatment.
Topics: Adult; Biomarkers; Breast Neoplasms; Female; Fibrinogen; Humans; Kaplan-Meier Estimate; Mastectomy; Middle Aged; Predictive Value of Tests; Preoperative Period; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Factors; ROC Curve | 2015 |
Downregulation of Integrins in Cancer Cells and Anti-Platelet Properties Are Involved in Holothurian Glycosaminoglycan-Mediated Disruption of the Interaction of Cancer Cells and Platelets in Hematogenous Metastasis.
Topics: Animals; Antineoplastic Agents; Blood Platelets; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Down-Regulation; Female; Fibrinogen; Gene Expression Regulation, Neoplastic; Glycosaminoglycans; Holothuria; Humans; Integrin beta1; Integrin beta3; Integrins; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Metastasis; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; RNA, Messenger; Thrombin; Time Factors; Tissue Inhibitor of Metalloproteinase-1 | 2015 |
Clinical and Prognostic Significance of Preoperative Plasma Fibrinogen Levels in Patients with Operable Breast Cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Disease-Free Survival; Female; Fibrinogen; Humans; Middle Aged; Preoperative Care; Prognosis; Retrospective Studies; Survival Analysis | 2016 |
PEG-fibrinogen hydrogels for three-dimensional breast cancer cell culture.
Topics: Breast Neoplasms; Cell Proliferation; Female; Fibrinogen; Humans; Hydrogels; MCF-7 Cells; Models, Biological; Polyethylene Glycols | 2017 |
A liver microphysiological system of tumor cell dormancy and inflammatory responsiveness is affected by scaffold properties.
Topics: alpha 1-Antitrypsin; Antineoplastic Agents; Breast Neoplasms; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; Chemokines; Cluster Analysis; Cytokines; Female; Fibrinogen; Hepatocytes; Humans; Hydrogels; Immunoassay; Intercellular Signaling Peptides and Proteins; Microfluidics; Polystyrenes; Signal Transduction; Tissue Scaffolds | 2016 |
Relation between hemostatic parameters and prognostic/predictive factors in breast cancer.
Topics: Adult; Aged; Anticoagulants; Antithrombin III; Axilla; Biomarkers, Tumor; Breast Neoplasms; C-Reactive Protein; Case-Control Studies; Factor IX; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Predictive Value of Tests; Prognosis; Protein S; Receptor, ErbB-2; Receptors, Steroid; Tumor Suppressor Protein p53; von Willebrand Factor | 2008 |
The VE-cadherin binding domain of fibrinogen induces endothelial barrier permeability and enhances transendothelial migration of malignant breast epithelial cells.
Topics: Antigens, CD; Breast Neoplasms; Cadherins; Cell Membrane Permeability; Cell Movement; Cell Proliferation; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Female; Fibrinogen; Fluorescent Antibody Technique, Indirect; Humans; Microcirculation; Microscopy, Confocal; Neovascularization, Pathologic; Umbilical Veins | 2009 |
Effect of aromatase inhibitors on lipid metabolism, inflammatory response and antioxidant balance in patients with breast carcinoma.
Topics: alpha-Tocopherol; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; C-Reactive Protein; Fibrinogen; Humans; Lipoprotein(a); Lipoproteins, LDL; Lipoproteins, VLDL; Neopterin; Prognosis; Prospective Studies; Tamoxifen; Vitamin A | 2009 |
Quantitative assay for six potential breast cancer biomarker peptides in human serum by liquid chromatography coupled to tandem mass spectrometry.
Topics: Alpha-Globulins; Animals; Biomarkers, Tumor; Bradykinin; Breast Neoplasms; Cattle; Chromatography, Liquid; Complement C4a; Female; Fibrinogen; Humans; Linear Models; Plasma; Sensitivity and Specificity; Tandem Mass Spectrometry | 2010 |
Serum degradome markers for the detection of breast cancer.
Topics: Aged; Amino Acid Sequence; Area Under Curve; Biomarkers, Tumor; Blood Proteins; Bradykinin; Breast Neoplasms; Case-Control Studies; Chromatography, Liquid; Complement C4a; Female; Fibrinogen; Glycoproteins; Humans; Middle Aged; Molecular Sequence Data; Netherlands; Proteinase Inhibitory Proteins, Secretory; Proteomics; Tandem Mass Spectrometry | 2010 |
Haemorheological changes in African breast cancer patients.
Topics: Adult; Black People; Blood Viscosity; Breast Neoplasms; Case-Control Studies; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Mastectomy; Middle Aged; Nigeria; Risk | 2008 |
Fibrin β15-42 domain is cryptic in intact fibrinogen: comment on the study by A. Sahni et al.
Topics: Antigens, CD; Breast Neoplasms; Cadherins; Cell Membrane Permeability; Cell Movement; Endothelium, Vascular; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Peptide Fragments | 2010 |
Thrombin-activatable fibrinolysis inhibitor in breast cancer patients.
Topics: Biomarkers, Tumor; Breast Neoplasms; Carboxypeptidase B2; Case-Control Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans | 2011 |
Curcumin loaded fibrinogen nanoparticles for cancer drug delivery.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line; Cell Line, Tumor; Curcumin; Drug Delivery Systems; Female; Fibrinogen; Hemolysis; Humans; In Vitro Techniques; Male; Materials Testing; Mice; Nanocapsules; Nanotechnology; Particle Size; Prostatic Neoplasms | 2011 |
[Impact of new technologies on the rheological properties of blood in plastic surgery of the breast].
Topics: Biocompatible Materials; Blood Viscosity; Breast Neoplasms; Erythrocyte Deformability; Female; Fibrinogen; Hemoglobins; Humans; Mammaplasty; Ozone; Postoperative Period; Surgery, Plastic | 2012 |
The use of TachoSil for the prevention of postoperative complications after groin dissection in cases of gynecologic malignancy.
Topics: Aged; Aged, 80 and over; Antibiotic Prophylaxis; Breast Neoplasms; Case-Control Studies; Cellulitis; Drainage; Drug Combinations; Female; Fibrinogen; Groin; Humans; Lymph Node Excision; Lymphedema; Lymphocele; Middle Aged; Ovarian Neoplasms; Surgical Sponges; Surgical Wound Dehiscence; Surgical Wound Infection; Thrombin; Vulvar Neoplasms | 2012 |
Carotid intima-media thickness and laboratory parameters of atherosclerosis risk in patients with breast cancer.
Topics: Adult; Age Factors; Aged; Atherosclerosis; Breast Neoplasms; C-Reactive Protein; Carotid Intima-Media Thickness; Female; Fibrinogen; Humans; Logistic Models; Middle Aged; Neopterin; Risk Factors; Tunica Media | 2012 |
[The dynamics of alteration of liquors' proteins under malignant neoplasms].
Topics: Adult; Aged; Breast Neoplasms; Female; Fibrinogen; Humans; Lymph; Middle Aged; Neoplasm Staging; Serum Albumin; Serum Globulins | 2012 |
[Does the use of TachoSil allow to reduce the morbidity of axillary dissection?].
Topics: Axilla; Breast Neoplasms; Drug Combinations; Female; Fibrinogen; Humans; Lymph Node Excision; Lymphocele; Postoperative Complications; Thrombin | 2013 |
Plasma from cancer patients featuring a characteristic protein composition mediates protection against apoptosis.
Topics: alpha-2-Antiplasmin; Apoptosis; Blotting, Western; Breast Neoplasms; Caspase 8; Caspase 9; Caspases; Dimerization; Electrophoresis, Polyacrylamide Gel; fas Receptor; Female; Fibrinogen; Humans; Jurkat Cells; Laminin; Lung Neoplasms; Male; Mass Spectrometry; Neoplasms; Precipitin Tests; Prostatic Neoplasms; Signal Transduction; Ultraviolet Rays | 2002 |
[Effects of tamoxifen and estrogen replacement therapy on lipid metabolism and some other cardiovascular risk factors. A prospective study in hysterectomised women].
Topics: Administration, Cutaneous; Antithrombin III; Breast Neoplasms; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Depression; Estradiol; Estrogen Replacement Therapy; Female; Fibrinogen; Follow-Up Studies; Hot Flashes; Humans; Hyperlipidemias; Hysterectomy; Italy; Lipids; Middle Aged; Ovariectomy; Platelet Count; Prospective Studies; Risk Factors; Tamoxifen; Triglycerides | 2003 |
Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against alpha-Enolase.
Topics: Adenocarcinoma; Antibodies, Monoclonal; B-Lymphocytes; Blood Cells; Breast Neoplasms; Carboxypeptidase B; Carboxypeptidases; Depression, Chemical; Female; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Leukocytes; Neoplasm Invasiveness; Neoplasm Proteins; Peptide Fragments; Phosphopyruvate Hydratase; Plasminogen; Protein Binding; Subcellular Fractions; Thrombin; Tissue Plasminogen Activator; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 2003 |
Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells.
Topics: Breast Neoplasms; Cell Movement; Dose-Response Relationship, Drug; Female; Fibrinogen; Humans; Integrin alphaVbeta3; Matrix Metalloproteinase 9; Neoplasm Metastasis; Protein Binding; Tumor Cells, Cultured; Up-Regulation; Vitronectin | 2003 |
Effect of tamoxifen on fibrinogen, D-dimer, lipid and lipoprotein concentrations in breast cancer patients.
Topics: Adult; Aged; Breast Neoplasms; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lipids; Lipoprotein(a); Lipoproteins; Middle Aged; Tamoxifen; Triglycerides | 2003 |
Platelet adhesion in breast cancer: development and application of a novel assay.
Topics: Blood Platelets; Breast Diseases; Breast Neoplasms; Carcinoma; Cohort Studies; Detergents; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Middle Aged; Neoplasm Metastasis; Octoxynol; P-Selectin; Pilot Projects; Plasma; Platelet Adhesiveness; Platelet Function Tests | 2004 |
Peptide profiling in epithelial tumor plasma by the emerging proteomic techniques.
Topics: Adult; Aged; Alpha-Globulins; Amino Acid Sequence; Breast Neoplasms; Chromatography, High Pressure Liquid; Female; Fibrinogen; Gene Expression Profiling; Humans; Lasers; Male; Mass Spectrometry; Melanoma; Neoplasm Proteins; Peptides; Proteomics; Skin Neoplasms | 2005 |
Gene regulation in an MCF-7 cell line that naturally expresses an estrogen receptor unable to directly bind DNA.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Clone Cells; Dose-Response Relationship, Drug; Estradiol; Estrogen Receptor alpha; Fibrinogen; Gene Expression Regulation, Neoplastic; Gene Transfer Techniques; Humans; Neoplasms, Hormone-Dependent; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction; Receptors, Estrogen; Receptors, G-Protein-Coupled; Receptors, Progesterone; RNA Interference; RNA, Small Interfering; Trefoil Factor-1; Tumor Suppressor Proteins | 2005 |
Enzymes that hydrolyze adenine nucleotides in platelets from breast cancer patients.
Topics: 5'-Nucleotidase; Adenine Nucleotides; Adult; Aged; Analysis of Variance; Apyrase; Blood Platelets; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fibrinogen; Humans; Hydrolysis; Immunohistochemistry; Middle Aged; Neoplasm Staging; Platelet Aggregation; Prothrombin Time; Tamoxifen | 2005 |
Declining plasma fibrinogen alpha fragment identifies HER2-positive breast cancer patients and reverts to normal levels after surgery.
Topics: Amino Acid Sequence; Automation; Biomarkers, Tumor; Breast Neoplasms; False Positive Reactions; Female; Fibrinogen; Humans; Longitudinal Studies; Molecular Sequence Data; Peptide Fragments; Protein Array Analysis; Receptor, ErbB-2; Reference Values; Reproducibility of Results; Robotics | 2006 |
Effects of breast cancer and mastectomy on fibrinolytic activity in African women.
Topics: Adult; Africa; Breast Neoplasms; Female; Fibrinogen; Fibrinolysis; Humans; Mastectomy; Middle Aged; Serum Globulins | 2006 |
131-I-labeled antibodies to human fibrinogen. Diagnostic studies and therapeutic trials.
Topics: Antibodies; Antifibrinolytic Agents; Brain Neoplasms; Breast Neoplasms; Carcinoma; Fibrinogen; Fibrinolytic Agents; Humans; Iodine Isotopes; Iodine Radioisotopes; Melanoma; Neoplasms; Radionuclide Imaging; Sarcoma | 1967 |
Acute right heart failure during treatment with epsilon amino caproic acid (E-ACA).
Topics: Acute Disease; Aminocaproates; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Breast Neoplasms; Female; Fibrinogen; Heart Failure; Humans; Middle Aged | 1967 |
Comparative in vivo and in vitro studies of fibrinopeptide A and factor XIII subunit A levels as indicators of thrombin generation.
Topics: Adolescent; Adult; Aged; Breast Neoplasms; Factor XIII; Female; Fibrinogen; Fibrinopeptide A; Humans; Intestinal Diseases; Leukemia; Male; Middle Aged; Thrombin; Transglutaminases | 1984 |
Blood coagulation in patients with benign and malignant tumours before and after surgery. Special reference to thromboplastin generation in monocytes.
Topics: Blood Coagulation; Breast Neoplasms; Factor VII; Factor VIII; Female; Fibrinogen; Humans; Male; Monocytes; Neoplasms; Postoperative Period; Prostatic Hyperplasia; Thromboplastin; Thyroid Neoplasms; Time Factors; Urinary Bladder Neoplasms | 1984 |
Interaction of human tumor cells with human platelets and the coagulation system.
Topics: Adenocarcinoma; Blood Platelets; Breast Neoplasms; Cell Line; Cells, Cultured; Factor VII; Factor X; Fibrin; Fibrinogen; Hemostasis; Humans; In Vitro Techniques; Iodine Radioisotopes; Melanoma | 1983 |
The relevance of platelet and fibrinogen kinetics and coagulation studies to extent of disease and performance status in patients with adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Blood Coagulation; Blood Platelets; Breast Neoplasms; Colonic Neoplasms; Female; Fibrinogen; Half-Life; Humans; Kinetics; Male; Middle Aged; Ovarian Neoplasms | 1980 |
Blood coagulation during adjuvant epirubicin/cyclophosphamide chemotherapy in patients with primary operable breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antithrombin III; Blood Coagulation; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Middle Aged; Plasminogen Inactivators; Prospective Studies; Protein C; Thrombophlebitis | 1996 |
Effect of the potent aromatase inhibitor fadrozole hydrochloride (CGS 16949A) in postmenopausal women with breast carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antithrombin III; Aromatase Inhibitors; Breast Neoplasms; Cardiovascular Diseases; Cholesterol; Enzyme Inhibitors; Estrogen Antagonists; Fadrozole; Female; Fibrinogen; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Middle Aged; Postmenopause; Protein C; Protein S; Risk Factors; Triglycerides | 1999 |
Fibrinogen assembly, secretion, and deposition into extracellular matrix by MCF-7 human breast carcinoma cells.
Topics: Amidohydrolases; Breast Neoplasms; Carcinoma, Hepatocellular; Extracellular Matrix; Female; Fibrinogen; Glycosylation; Humans; Liver Neoplasms; Macromolecular Substances; Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured; Tunicamycin | 2000 |
Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy.
Topics: Adult; Aged; Antineoplastic Agents; Blood Cell Count; Blood Viscosity; Breast Neoplasms; Carcinoma; Cell Hypoxia; Cohort Studies; Disease Progression; Erythrocyte Aggregation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Genital Neoplasms, Female; Germany; Hematocrit; Hemorheology; Humans; Life Tables; Microcirculation; Middle Aged; Neoplasm Metastasis; Neoplastic Cells, Circulating; Ovarian Neoplasms; Prospective Studies; Risk Factors; Survival Analysis; Thrombophilia; Uterine Cervical Neoplasms; Uterine Neoplasms; Venous Thrombosis | 2000 |
A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fibrinogen; Fibronectins; Humans; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Neovascularization, Pathologic; Osteosarcoma; Peptide Fragments; Receptors, Vitronectin; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |
Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factor.
Topics: Adult; Aged; Biomarkers; Breast Neoplasms; Case-Control Studies; Cross-Sectional Studies; Female; Fibrinogen; Hematologic Neoplasms; Humans; Male; Middle Aged; P-Selectin; Plasminogen Inactivators; Solubility; von Willebrand Factor | 2001 |
Correspondence re: N. C. Denko and A. J. Giaccia, tumor hypoxia, the physiological link between Trousseau's syndrome (carcinoma-induced coagulopathy) and metastasis. Cancer Res., 61: 795-798, 2001.
Topics: Blood Coagulation Disorders; Breast Neoplasms; Cell Hypoxia; Female; Fibrin; Fibrinogen; Humans; Middle Aged; Neoplasm Metastasis | 2001 |
Prognostic role of plasmaviscosity in breast cancer.
Topics: Blood Viscosity; Breast Neoplasms; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Reference Values; Retrospective Studies; Survival Analysis | 2002 |
The diagnostic value of serum copper levels and other hematochemical parameters in malignancies.
Topics: Alpha-Globulins; Blood Sedimentation; Breast Neoplasms; Copper; Fibrinogen; Humans; Iron; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Multiple Myeloma; Neoplasms | 1978 |
[Biological significance of fibrinopeptide A elevation in the blood].
Topics: Breast Neoplasms; Bronchial Neoplasms; Fatty Liver; Female; Fibrinogen; Fibrinopeptide A; Half-Life; Humans; Liver Cirrhosis; Lymphoma, Non-Hodgkin; Pleural Effusion | 1977 |
[Determination of some coagulation parameters in patients with neoplasms].
Topics: Blood Coagulation; Breast Neoplasms; Factor V; Factor X; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Multiple Myeloma; Neoplasm Metastasis | 1978 |
[Blood coagulation disorders and tumor growth].
Topics: Adult; Anticoagulants; Antineoplastic Agents; Blood Coagulation Disorders; Breast Neoplasms; Cell Line; Cells, Cultured; Drug Therapy, Combination; Female; Fibrin; Fibrinogen; Humans; Lung Neoplasms; Male; Middle Aged; Stomach Neoplasms; Surface Properties; Tumor Cells, Cultured | 1991 |
Haemostatic abnormalities and outcome in patients with operable breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Fibrinopeptide B; Hemostasis; Humans; Middle Aged; Peptide Fragments; Predictive Value of Tests; Prognosis; Recurrence; Time Factors | 1990 |
[Fibrin pleurodesis in malignant pleural effusions].
Topics: Adult; Aged; Antifibrinolytic Agents; Aprotinin; Breast Neoplasms; Carcinoma, Bronchogenic; Carcinoma, Renal Cell; Drainage; Female; Fibrinogen; Heparin; Humans; Lymphoma; Male; Middle Aged; Neoplasms; Pleura; Pleural Effusion; Posture; Prognosis; Thrombin | 1985 |
In vivo measurements of fibrin formation and fibrinolysis in operable breast cancer.
Topics: Breast Neoplasms; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Fibrinopeptide A; Fibrinopeptide B; Humans; Peptide Fragments; Plasminogen Activators | 1989 |
Fibrin(ogen) peptides in early breast cancer.
Topics: Biomarkers, Tumor; Breast Neoplasms; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Fibrinopeptide B; Humans; Peptide Fragments; Time Factors | 1989 |
Hemorheologic variables in breast cancer patients at the time of diagnosis and during treatment.
Topics: Blood Sedimentation; Blood Viscosity; Breast Neoplasms; Erythrocyte Aggregation; Female; Fibrinogen; Hematocrit; Humans; Middle Aged | 1988 |
Elevated fibrinopeptide A levels in patients with clinically localised breast carcinoma.
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Female; Fibrinogen; Fibrinopeptide A; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests | 1987 |
Adhesion of human breast cancer cell line MCF-7 to human vascular endothelial cells in culture. Enhancement by activated platelets.
Topics: Adenosine Diphosphate; Breast Neoplasms; Cell Adhesion; Cell Cycle; Cells, Cultured; Endothelium, Vascular; Epinephrine; Extracellular Matrix; Female; Fibrinogen; Heparin; Hirudins; Humans; Microscopy, Electron; Microscopy, Electron, Scanning; Oligopeptides; Platelet Aggregation; Thrombin | 1987 |
Hypercoagulable state induced by cytostatic drugs in stage II breast cancer patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation Disorders; Breast Neoplasms; Female; Fibrinogen; Humans; Middle Aged; Neoplasm Staging; Partial Thromboplastin Time; Platelet Adhesiveness; Platelet Aggregation; Prospective Studies; Prothrombin Time; Risk; Thrombin Time | 1986 |
[Cryoglobulin (cryofibrinogen) in tumor patients].
Topics: Blood Protein Disorders; Breast Neoplasms; Cryoglobulins; Diagnosis, Differential; Fibrinogen; gamma-Globulins; Humans; Lung Neoplasms; Neoplasms | 1966 |
[Plasma erythrocyte sedimentation under the effect of heat and other stabilizing factors].
Topics: Aminobenzoates; Blood Coagulation Tests; Blood Sedimentation; Breast Neoplasms; Bronchial Neoplasms; Bronchiectasis; Cholecystitis; Colonic Neoplasms; Female; Fibrinogen; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Pelvic Neoplasms; Protamines; Rectal Neoplasms; Streptokinase; Temperature; Thrombophlebitis; Toxoplasmosis; Urogenital Neoplasms | 1970 |
[Hyperfibrinogenemia in breast carcinoma].
Topics: Breast Neoplasms; Female; Fibrinogen; Humans; Neoplasm Metastasis | 1974 |
Fibrinolysis in human malignant tumours.
Topics: Breast Neoplasms; Colonic Neoplasms; Esophageal Neoplasms; Fibrin; Fibrinogen; Fibrinolysis; Gallbladder Neoplasms; Humans; Lymphatic Metastasis; Neoplasms; Pancreatic Neoplasms; Rectal Neoplasms; Stomach Neoplasms | 1973 |
Fibrinogen degradation products in serum from patients with cancer.
Topics: Aminocaproates; Blood Coagulation; Breast Neoplasms; Colonic Neoplasms; Female; Fibrin; Fibrinogen; Fibrinolysis; Gastrointestinal Neoplasms; Humans; Immunoelectrophoresis; Intestinal Neoplasms; Kidney Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Prostatic Neoplasms; Rectal Neoplasms; Thrombin; Urinary Bladder Neoplasms; Urogenital Neoplasms | 1973 |
Fibrinolytic activity of human carcinomas. A comparative methodological study.
Topics: Animals; Blood Coagulation Factors; Breast Neoplasms; Bronchial Neoplasms; Cattle; Female; Fibrinogen; Fibrinolytic Agents; Histocytochemistry; Humans; Plasminogen | 1973 |
Hypofibrinogenemia due to L-asparaginase: studies of fibrinogen survival using autologous 131-I-fibrinogen.
Topics: Adenocarcinoma; Adult; Afibrinogenemia; Asparaginase; Breast Neoplasms; Female; Fibrinogen; Humans; Iodine Radioisotopes; Leukemia, Myeloid; Lymphoma, Large B-Cell, Diffuse; Male; Melanoma; Middle Aged; Neuroblastoma | 1970 |
[Potentiation of antineoplastic agents--significance of combination with urokinase].
Topics: Adult; Animals; Antineoplastic Agents; Breast Neoplasms; Dextrans; Drug Synergism; Female; Fibrinogen; Fibrinolytic Agents; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Rectal Neoplasms; Sarcoma, Yoshida; Splenic Neoplasms; Stomach Neoplasms | 1971 |
Acute fibrinolysis following craniotomy and removal of metastatic tumor of the cerebellum. Case report.
Topics: Adenocarcinoma; Aminocaproates; Breast Neoplasms; Cerebellar Neoplasms; Cerebral Hemorrhage; Craniotomy; Female; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Neoplasm Metastasis | 1970 |
Microangiopathic haemolytic anaemia and mucin-forming adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Anemia, Hemolytic; Breast Neoplasms; Female; Fibrinogen; Humans; Lung Neoplasms; Male; Middle Aged; Mucins; Neoplasm Metastasis; Stomach Neoplasms; Thrombocytopenia; Thrombosis | 1970 |
[State of the anticoagulant system in patients with cancer as an indication of the reactivity of the organism].
Topics: Anticoagulants; Antithrombins; Blood Coagulation; Breast Neoplasms; Female; Fibrinogen; Fibrinolysis; Heparin; Humans; Lung Neoplasms; Neoplasms; Skin Tests; Stomach Neoplasms | 1968 |
Urokinase therapy in pulmonary thromboembolism.
Topics: Adult; Aged; Angiography; Arteriosclerosis; Blood Coagulation Tests; Brain Diseases; Breast Neoplasms; Fibrinogen; Fibrinolytic Agents; Humans; Liver Cirrhosis; Middle Aged; Obesity; Phlebitis; Plasminogen; Prothrombin Time; Pulmonary Embolism; Radionuclide Imaging; Schizophrenia; Thromboembolism | 1968 |